Literature DB >> 28112680

How does leptin restore euglycemia in insulin-deficient diabetes?

Douglas Oberlin, Christoph Buettner.   

Abstract

Insulin replacement is the cornerstone of type 1 diabetes (T1D) treatment; however, glycemic control remains a challenge. Leptin has been shown to effectively restore euglycemia in rodent models of T1D; however, the mechanism or mechanisms by which leptin exerts glycemic control are unclear. In this issue of the JCI, Perry and colleagues provide evidence that suppression of lipolysis is a key facet of leptin-mediated restoration of euglycemia. However, more work remains to be done to fully understand the antidiabetic mechanisms of leptin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28112680      PMCID: PMC5272168          DOI: 10.1172/JCI91880

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Changes in plasma leptin during the treatment of diabetic ketoacidosis.

Authors:  E H Hathout; J Sharkey; M Racine; D Ahn; J W Mace; M F Saad
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

2.  Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats.

Authors:  Shuji Hidaka; Hironobu Yoshimatsu; Seiya Kondou; Yoshio Tsuruta; Kyoko Oka; Hitoshi Noguchi; Kenjirou Okamoto; Hiroshi Sakino; Yasushi Teshima; Toshimitsu Okeda; Toshiie Sakata
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

3.  Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.

Authors:  Owen Chan; Karen Inouye; Mladen Vranic; Stephen G Matthews
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

4.  Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice.

Authors:  Teppei Fujikawa; Jen-Chieh Chuang; Ichiro Sakata; Giorgio Ramadori; Roberto Coppari
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

5.  Mechanism for leptin's acute insulin-independent effect to reverse diabetic ketoacidosis.

Authors:  Rachel J Perry; Liang Peng; Abudukadier Abulizi; Lynn Kennedy; Gary W Cline; Gerald I Shulman
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

6.  Direct effect of glucocorticoids on lipolysis in adipocytes.

Authors:  Chong Xu; Jinhan He; Hongfeng Jiang; Luxia Zu; Wenjie Zhai; Shenshen Pu; Guoheng Xu
Journal:  Mol Endocrinol       Date:  2009-05-14

7.  Ketoacidosis in pancreatectomized man.

Authors:  A J Barnes; S R Bloom; K Goerge; G M Alberti; P Smythe; F P Alford; D J Chisholm
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

Review 8.  Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.

Authors:  Mi-Jeong Lee; Pornpoj Pramyothin; Kalypso Karastergiou; Susan K Fried
Journal:  Biochim Biophys Acta       Date:  2013-06-02

9.  Making insulin-deficient type 1 diabetic rodents thrive without insulin.

Authors:  Xinxin Yu; Byung-Hyun Park; May-Yun Wang; Zhao V Wang; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

10.  Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis.

Authors:  Rachel J Perry; Xian-Man Zhang; Dongyan Zhang; Naoki Kumashiro; Joao-Paulo G Camporez; Gary W Cline; Douglas L Rothman; Gerald I Shulman
Journal:  Nat Med       Date:  2014-06-15       Impact factor: 53.440

View more
  7 in total

Review 1.  Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor.

Authors:  Daniel M Cohen; David J Steger
Journal:  Trends Endocrinol Metab       Date:  2017-05-08       Impact factor: 12.015

2.  The circulating metabolome of human starvation.

Authors:  Matthew L Steinhauser; Benjamin A Olenchock; John O'Keefe; Mingyue Lun; Kerry A Pierce; Hang Lee; Lorena Pantano; Anne Klibanski; Gerald I Shulman; Clary B Clish; Pouneh K Fazeli
Journal:  JCI Insight       Date:  2018-08-23

Review 3.  The endocrine function of adipose tissues in health and cardiometabolic disease.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  Nat Rev Endocrinol       Date:  2019-07-11       Impact factor: 43.330

Review 4.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

5.  A neural basis for brain leptin action on reducing type 1 diabetic hyperglycemia.

Authors:  Shengjie Fan; Yuanzhong Xu; Yungang Lu; Zhiying Jiang; Hongli Li; Jessie C Morrill; Jing Cai; Qi Wu; Yong Xu; Mingshan Xue; Benjamin R Arenkiel; Cheng Huang; Qingchun Tong
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

6.  Leptin in the Commissural Nucleus of the Tractus Solitarius (cNTS) and Anoxic Stimulus in the Carotid Body Chemoreceptors Increases cNTS Leptin Signaling Receptor and Brain Glucose Retention in Rats.

Authors:  Mónica Lemus; Cynthia Mojarro; Sergio Montero; Mario Ramírez-Flores; José Torres-Magallanes; Adrián Maturano-Melgoza; Elena Roces de Álvarez-Buylla
Journal:  Medicina (Kaunas)       Date:  2022-04-16       Impact factor: 2.948

7.  Chronic Antidiabetic Actions of Leptin: Evidence From Parabiosis Studies for a CNS-Derived Circulating Antidiabetic Factor.

Authors:  Alexandre A da Silva; John E Hall; Xuemei Dai; Zhen Wang; Mateus C Salgado; Jussara M do Carmo
Journal:  Diabetes       Date:  2021-08-03       Impact factor: 9.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.